Less Ads, More Data, More Tools Register for FREE

Broker tips: Lloyds, Aggreko, BAE Systems

Thu, 01st Aug 2013 11:08

Canaccord Genuity has placed its 'neutral' rating and target price for Lloyds under review, highlighting the possibility of a dividend next year given the bank's optimistic outlook in its first-half results.The broker said that its 'neutral' recommendation had been based on the assumption that the lender would not be in the position to resume dividends until the end of 2014. "But, with the B3 fully loaded core tier-one ratio at 9.6% at H113 and earnings momentum exceeding our estimates, it now appears LLOY could be in a position to pay a 2014 interim," said analyst Gareth Hunt.Investec has retained its 'add' recommendation and 1,900p target price for temperature control and power supply company Aggreko, but admitted that it is a 'tough stock to call'."Aggreko is likely have a weaker day today in our view, especially with reduced fleet capex guidance and there is still a subdued message around the Power Projects business. Cash remains strong, however, and the Local Business continues to perform well."Jefferies has maintained its 'buy' rating and 350p target price for defence, security and aerospace firm BAE Systems, saying that the group's first-half results give it confidence in its full-year forecasts."We believe BAE's valuation has for at least two years been depressed by uncertainty about future US Defense Budgets, the possible impacts of Sequester and the protracted Typhoon VoP negotiations. We see much in the 1H13 result that should lend credibility and solidity to earnings in FY13 and FY14.BC

Related Shares

More News
9 Dec 2022 10:27

Aggreko to buy Crestchic in £122m deal

(Sharecast News) - Temporary power supplier Aggreko said on Friday that it has agreed to buy specialist equipment provider Crestchic in a £122m d...

6 Aug 2021 18:20

IN BRIEF: Edinburgh court sanctions Albion's takeover of Aggreko

IN BRIEF: Edinburgh court sanctions Albion's takeover of Aggreko

2 Aug 2021 10:07

Albion puts in place financing for GBP2.32 billion Aggreko acquisition

Albion puts in place financing for GBP2.32 billion Aggreko acquisition

8 Jul 2021 21:32

IN BRIEF: Aggreko takeover clears antitrust and regulatory hurdle

IN BRIEF: Aggreko takeover clears antitrust and regulatory hurdle

26 May 2021 11:15

TOP NEWS: Carlyle offers GBP958 million for asthma drug maker Vectura

TOP NEWS: Carlyle offers GBP958 million for asthma drug maker Vectura

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.